The Patent Finder

Prescient Neuropharma, Inc.

Also on record
Records under this name other than patents Prescient Neuropharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 6 of 6 · Back to Prescient Neuropharma, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,084,425Dopaminergic neuronal survival-promoting factors and uses thereof
Formerly held
Lapsed on the fee record
Ended Dec 27, 2019 · USPTO record
Lapsed on the fee recordEnded Dec 27, 2019USPTO record
US 9,115,208Dopaminergic neuronal survival-promoting factors and uses thereof
Formerly held
Lapsed on the fee record
Ended Aug 25, 2019 · USPTO record
Lapsed on the fee recordEnded Aug 25, 2019USPTO record
US 7,034,0552-aminoindane analogs
Lapsed on the fee record
Ended Apr 25, 2010 · USPTO record
Lapsed on the fee recordEnded Apr 25, 2010USPTO record
US 6,784,202Cubane derivatives as metabotropic glutamate receptor agonists or antagonists and process for their preparation
Formerly held
Lapsed on the fee record
Ended Aug 31, 2008 · USPTO record
Lapsed on the fee recordEnded Aug 31, 2008USPTO record
US 6,699,909Novel Aminoindanes
Formerly held
Lapsed on the fee record
Ended Mar 2, 2008 · High confidence
Lapsed on the fee recordEnded Mar 2, 2008High confidence
US 6,465,248Methods for producing and preparing cells for cell therapy
Lapsed on the fee record
Ended Oct 15, 2006 · USPTO record
Lapsed on the fee recordEnded Oct 15, 2006USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited